Fulcrum Therapeutics, Inc. (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined ...

What are your upcoming plans with respect to disease portfolio, partnerships, and molecule discovery and manufacturing in FY25 and upcoming financial year? LMS plans to expand its therapeutic ...

Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of ...

Acetylsalicylic is readily available in Aspirin tablets. Chemically, it is a useful molecule. It can be converted to salicylic acid and then phenol, which is an extremely useful precursor. Also, the ...

Add a description, image, and links to the molecule-driver topic page so that developers can more easily learn about it.

small-molecule dual inhibitor of LSD1 (Lysine-specific histone demethylase 1A) and HDAC6 (Histone deacetylase 6) within the CoREST (Co-repressor of Repressor Element-1 Silencing Transcription ...

Semaglutide, the active ingredient in Novo Nordisk’s Ozempic, is a GLP-1 molecule that regulates blood sugar in diabetes patients. It is also the active ingredient in Wegovy, Ozempic’s ...

About molecular glue degraders Conventional small molecule therapeutics work via a drug-induced interference with a protein activity. This limitation to agonistic or antagonistic functions renders ...

Due to the capital requirements and developmental timelines of APX3330, an oral small-molecule inhibitor of Ref-1 for the treatment of non-proliferative diabetic retinopathy, the company will seek ...

Immune cells are exposed to a molecule from prostate cancer cells, and then infused back into the body. It can extend survival in people with metastatic prostate cancer. There is also dendritic ...